NASDAQ:CGEN
Compugen Ltd. Stock News
$2.16
+0.170 (+8.54%)
At Close: May 02, 2024
Compugen to Release Second Quarter Results on Thursday, August 4, 2022
07:00am, Thursday, 21'st Jul 2022
HOLON, Israel , July 21, 2022 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today that the Comp
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
01:23pm, Tuesday, 10'th May 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Pfizer Acquires Biohaven For $11B
Pfizer Inc (NYSE: PFE) will acquire Biohaven Pharmaceutical Hold
10 Top Penny Stocks Cathie Wood ARK Invest Owns, Time To Buy?
12:56pm, Thursday, 28'th Apr 2022
Are these Cathie Wood penny stocks a buy right now? The post 10 Top Penny Stocks Cathie Wood ARK Invest Owns, Time To Buy?
Ensign Group (ENSG) Ups Credit Facility to $600M to Fuel Growth
06:55pm, Wednesday, 13'th Apr 2022 Zacks Investment Research
Ensign Group (ENSG) expands its credit facility by $250 million to continue with its series of acquisitions, renovation of projects, business requirements et al.
UnitedHealth (UNH) to Spend $5.4B on Home-Health Profile Boost
06:41pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
UnitedHealth (UNH) intends to combine its Optum business with LHC Group to expand its reach in the healthcare-at-home market.
UnitedHealth (UNH) Arm Optum Acquires Refresh Mental Health
02:25pm, Friday, 25'th Mar 2022 Zacks Investment Research
UnitedHealth (UNH) unit Optum's acquisition of Refresh Mental Health comes at a time when demand for behavioral health services is on the rise.
Ensign Group (ENSG) Up 9.9% in 3 Months: More Room to Grow?
03:10pm, Tuesday, 15'th Mar 2022 Zacks Investment Research
Ensign Group (ENSG) expects annual revenues for 2022 in the band of $2.93-$2.98 billion, whose midpoint signals a 12.4% rise from the 2021 reported figure.
Compugen To Present New Insights into the Tumor Microenvironment Using Single Cell Spatial Transcriptomics at Keystone Symposium
07:00am, Monday, 14'th Mar 2022
HOLON, Israel , March 14, 2022 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that it has
Compugen to Present at the Oppenheimer 32nd Annual Global Healthcare Conference
07:05am, Wednesday, 09'th Mar 2022
HOLON, Israel, March 9, 2022 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that managem
5 Best Penny Stocks Under $5 To Buy According To Analysts Right Now
04:42pm, Friday, 25'th Feb 2022 PennyStocks
Today we look at five penny stocks to buy according to some of Wall Street's analyst firms.
The post 5 Best Penny Stocks Under $5 To Buy According To Analysts Right Now appeared first on Penny Stocks
5 Best Penny Stocks Under $5 To Buy According To Analysts Right Now
11:42am, Friday, 25'th Feb 2022
Today we look at five penny stocks to buy according to some of Wall Street's analyst firms. The post 5 Best Penny Stocks Under $5 To Buy According To Analysts Right Now appeared first on Penny Stocks
Compugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q4 2021 Results - Earnings Call Transcript
05:56pm, Thursday, 24'th Feb 2022 Seeking AlphaCompugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q4 2021 Results - Earnings Call Transcript
12:56pm, Thursday, 24'th Feb 2022
Compugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q4 2021 Results - Earnings Call Transcript
Compugen GAAP EPS of -$0.10 beats by $0.04
12:06pm, Thursday, 24'th Feb 2022 Seeking Alpha
Compugen press release (CGEN): Q4 GAAP EPS of -$0.10 beats by $0.04.As of December 31, 2021, cash, cash related accounts, short-term and long-term bank deposits totaled to…
Compugen Q4 2021 Earnings Preview
06:57pm, Wednesday, 23'rd Feb 2022 Seeking Alpha
Compugen (NASDAQ:CGEN) is scheduled to announce Q4 earnings results on Thursday, February 24th, before market open.The consensus EPS Estimate is -$0.13 (-30.0% Y/Y) and the…
